Jonathan Kipnis
10Patents
3h-index
11Co-inventors
53Inventor score
Filing activity: Jan 22, 2001 → Jul 15, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6844314B2 | Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy | Human Necessities | 57 | Expired |
| US7351686B2 | Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides | Human Necessities | 17 | Expired |
| US7407936B2 | Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy | Human Necessities | 13 | Expired |
| US8828404B2 | Vaccine and method for treatment of neurodegenerative diseases | Human Necessities | 2 | Active |
| US11679104B2 | Compositions and methods of enhancing the homing and/or engraftment of hematopoietic cells in the central nervous system | Human Necessities | 0 | Active |
| US9517256B2 | Vaccine and method for treatment of neurodegenerative diseases | Human Necessities | 0 | Active |
| US12352767B2 | Method of treating cognitive decline associated with neurological diseases based on a decrease in FLT4 expression or activity | Physics | 0 | Active |
| US11389509B1 | Methods for treatment of social dysfunction neurological disorders and seizures | Human Necessities | 0 | Active |
| US11312775B2 | Methods for treatment or prevention of a neurological immunity disorder | Chemistry; Metallurgy | 0 | Active |
| US11944665B2 | Methods and compositions for modulating lymphatic vessels in the central nervous system | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.